Repeated intraperitoneal injections of crocidolite asbestos fibers induced diffuse malignant mesotheliomas in mice. A series of mesothelial cell lines was isolated from mice at different stages in the development of these tumors. The cell lines isolated from mice with mesotheliomas recapitulated their growth pattern in vivo and were tumorigenic when reinjected into syngeneic mice. Similar to human mesothelial cells, growth of the murine cell lines was stimulated by epidermal growth factor. Reactive mesothelial cells and mesotheliomas expressed the receptor for this growth factor. Crocidolite asbestos fibers have been reported to induce sustained expression of the c-fos and c-jun protooncogenes in rat pleural mesothelial cells in vitro (Heintz et al, Proc. Natl. Acad. Sci. USA 90: 3299-303, 1993). Human malignant mesotheliomas have been shown to express c-fos in situ (Ramael et al, Histol. Histopathol. 10: 639-643, 1995). Two of the cell lines derived from highly invasive murine mesotheliomas overexpressed c-fos and c-jun. This murine model recapitulates the histopathology, growth factor responses, and protooncogene expression of human malignant mesotheliomas.
Alberts AS, Falkson G., Goedhals L., Vorobiof DA, and van der Merwe CA (1988). Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers. J. Clin. Oncol. 6: 527-535.
2.
Amin KM, Litzky LA, Smythe WR, Mooney AM, Morris JM, Mews DJY, Pass HI, Kari C., Rodeck U., Fauscher FJ III, Kaiser LR, and Albelda SM (1995). Wilms' tumor/susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma. Am. J. Pathol. 146: 344-356.
3.
Angel P. and Karin M. (1991). The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta1072: 129-157.
4.
Baris I., Simonato L., Artvinli M., Pooley F., Saracci R., Skidmore J., and Wagner C. (1987). Epidemiological and environmental evidence of the health effects of exposure to erionite fibers: A four-year study in the Cappadocian region of Turkey. Int. J. Cancer39: 10-17.
5.
Bolen JW and Thorning D. (1980). A light and electron microscopical study concerning histogenetic relationships between the epithelial and the mesenchymal variants . Am. J. Surg. Pathol. 4: 451-464.
6.
Brasaemle DL and Attie AD (1988). Microelisa reader quantitation of fixed, stained, solubilized cells in microtitre dishes . Biotechniques6: 418-419.
7.
Chomczynski P. and Sacchi N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction . Anal. Biochem. 162: 156-159.
8.
Coleman M., Henderson DW, and Mukherjee TM (1989). The ultrastructural pathology of malignant pleural mesothelioma. Pathol. Ann. 24: 303-353.
9.
Craighead JE (1987). Current pathogenetic concepts of diffuse malignant mesothelioma. Human Pathol. 18: 544-557.
10.
Craighead JE , Akley NJ, Gould LB, and Libbus GL (1987). Characteristics of tumors and tumor cells cultured from experimental asbestos-induced mesotheliomas in rats. Am. J. Pathol. 129: 448-462.
11.
Craighead JE and Mossman BT (1982). The pathogenesis of asbestos-associated disease. N. Engl. J. Med. 306: 1446-1455.
12.
Davis JM, Dungworth DL, and Boorman GA (1996). Concordance in diagnosis of mesotheliomas. Toxicol. Pathol. 24: 662-663.
13.
Davis JMG (1974). Histogenesis and fine structure of peritoneal tumors produced in animals by injections of asbestos . J. Natl. Cancer Inst. 52: 1823-1837.
14.
Dazzi H., Hasleton PS, Thatcher N., Wilkes S., Swindell R., and Chatterjee AK (1990). Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin-embedded tissue and the F4, monoclonal antibody. Br. J. Cancer61: 924-926.
15.
Fitzpatrick DR, Peroni DJ, and Bielefeldt-Ohmann H. (1995 ). The role of growth factors and cytokines in the tumorigenesis and immunobiology of malignant mesothelioma. Am. J. Resp. Cell Mol. Biol. 12: 455-460.
16.
Gabrielson EW, Gerwin BI, Harris CC, Roberts AG, Sporn MD, and Lechner JF (1988). Stimulation of DNA synthesis in cultured primary human mesothelial cells by specific growth factors. FASEB J. 2: 2717-2721.
17.
Gerwin BI, Lechner JF, Reddel RR, Roberts AB, Robbins KC, Gabrielson EW, and Harris CC (1987). Comparison of production of transforming growth factor-β and platelet-derived growth factor by normal human mesothelial cells and mesothelial cell lines. Cancer Res. 47: 6180-6184.
18.
Heintz NH, Janssen YM, and Mossman BT (1993). Persistent induction of c-fos and c-jun expression by asbestos. Proc. Natl. Acad. Sci. USA90: 3299-3303.
19.
Janknecht R. , Cahill MA, and Nordheim A. (1995). Signal integration at the c-fos promoter. Carcinogenesis16: 443-450.
20.
Kafiri G., Thomas DM, Shepherd NA, Krausz T., Lane DP, and Hall PA (1992). p53 expression is common in malignant mesothelioma . Histopathology21: 331-334.
21.
Kim KH, Stellmach V., Javors J., and Fuchs E. (1987). Regulation of human mesothelial cell differentiation: opposing roles of retinoids and epidemal growth factor in the expression of intermediate filament proteins. J. Cell Biol. 105: 3039-3051.
22.
Langerak AW , Williamson KA, Miyagawa K., Hagemeijer A., Versnel MA, and Hastie ND (1995). Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression . Genes Chromosomes Cancer12: 87-96.
23.
Lechner JF, Laveck MA, Gerwin GI, and Matis EA (1989). Differential responses to growth factors by normal human mesothelial cultures from individual donors. J. Cell Physiol. 139: 295-300.
24.
Maheswaran S., Park S., Bernard A., Morris JF, Rauscher FJ III, Hill DE, and Haber DA (1993). Interaction between the p53 and Wilms tumor (WT1) gene products: Physical association and functional cooperation. Proc. Natl. Acad. Sci. USA90: 5100-5104.
25.
Mayall FG, Goddard H., and Gibbs AR (1992). p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections. J. Pathol. 168: 377-381.
26.
Moalli PA, Macdonald JL, Goodglick LA, and Kane A. (1987). Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am. J. Pathol. 128: 426-445.
27.
Morocz IA, Schmitter D., Lauber B., and Stahel RA (1994). Autocrine stimulation of a human lung mesothelioma cell line is mediated through the transforming growth factor α/epidermal growth factor receptor mitogenic pathway. Br. J. Cancer70: 850-856.
28.
Mossman BT, Faux S., Janssen Y., Jimenez LA, Timblin C., Zanella C., Goldberg J., Walsh E., Barchowsky A., and Driscoll K.Cell signalling pathways elicited by asbestos. Environ. Health Perspect. (in press).
29.
O'Connell TM and Rheinwald JG (1991). Biology of normal, malignant, and oncogene-transfected human mesothelial cells in culture . In: Cellular and Molecular Aspects of Fiber Carcinogenesis , CC Harris , JF Lechner , and BR Brinkley (eds). Cold Spring Harbor Laboratory Press, Plainview, New York, pp. 55-66.
30.
Park S., Schalling M., Bernard A., Maheswaran S., Shipley GC, Roberts D., Fletcher J., Shipman R., Rheinwald J., Demetri G., Griffin J., Minden M., Housman DE, and Haber DA (1993). The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nat. Genet. 4: 415-420.
31.
Peterson JT , Greenberg SD, and Buffler PA (1984) Non-asbestos-related malignant mesothelioma. Cancer54: 951-960.
32.
Pott F. and Friedrichs KH (1972) Tumors in rats after intraperitoneal injection of asbestos dusts. Naturwissenchaften59: 318-332.
33.
Ramael M., Segers K., Buysse C., Van den Bossche J., and Van Marck E. (1991). Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium . Virchows Arch A419: 171-175.
34.
Ramael M., Van den Bossche J., Buysse C., Deblier I., Segers K., and Van March E. (1995) Immunoreactivity for c-fos and c-myc protein with the monoclonal antibodies 14E10 and 6E10 in malignant mesothelioma and non-neoplastic mesothelium of the pleura. Histol. Histopathol. 10: 639-643.
35.
Rauscher FJ III (1993). The WT1 Wilms tumor gene product: A developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J. 7: 896-903.
36.
Rüther U., Komitowski D., Shubert FR, and Wagner EG (1989). c-fos expression induces bone tumors in transgenic mice. Oncogene4: 861-865.
37.
Saez E., Rutberg SE, Mueller E., Oppenheim H., Smoluk J., Yuspa SH, and Spiegelman BM (1995). c-fos is required for malignant progression of skin tumors. Cell82: 721-732.
38.
Selden RF (1987). Analysis of RNA by northern hybridization. In: Current Protocols in Molecular Biology, FM Ausubel, R Brent, RE Kingston, DD Moore , JG Seidman, JA Smith, and K Struhl (eds). John Wiley and Sons, New York, pp. 4.9.1-4.9.7.
39.
Stanton MF and Wrench C. (1972). Mechanisms of mesothelioma induction with asbestos and fibrous glass. J. Natl. Cancer Inst. 48: 797-821.
40.
Urabe A., Nakayama J., Taniguchi S., Terao H., and Hori Y. (1992). Expression of the c-fos oncogene in chemically-induced mouse tumours and in human skin tumors. J. Pathol. 168: 281-286.
41.
van der Meeren A., Levy F., Renier A., Katz A., and Jaurand MD (1990). Effect of epidermal growth factor on rat pleural mesothelial cell growth. J. Cell. Physiol . 144: 137-143.
42.
Versnel MA, Hagemeijer A., Bouts MJ, vander Kwast TH, and Googsteden HC (1988). Expression of c-sis (PDGF-β chain) and PDGF α-chain genes in ten human malignant mesothelioma cell lines derived from primary and metastatic tumors. Oncogene2: 601-606.
43.
Wagner JC and Berry G. (1969). Mesotheliomas in rats following inoculation with asbestos. Br. J. Cancer23: 567-581.
44.
Wagner JC, Berry G., Skidmore JW, and Timbrell V. (1974). The effects of the inhalation of asbestos in rats. Br. J. Cancer29: 252-269.
45.
Walker C., Bermudez E., Stewart W., Bonner J., Molloy CJ, and Everitt J. (1992). Characterization of platelet-derived growth factor and platelet-derived factor receptor expression in asbestos-induced rat mesothelioma . Cancer Res. 52: 301-306.
46.
Walker C., Everitt J., Ferriola PC, Stewart W., Mangum J., and Bermudez E. (1995). Autocrine growth stimulation by transforming growth factor α in asbestos-transformed rat mesothelial cells. Cancer Res. 55: 530-536.
47.
Walker C., Rutten F., Yuan X., Pass H., Mew DM, and Everitt J. (1994). Wilms' tumor suppressor gene expression in rat and human mesothelioma. Cancer Res. 54: 3101-3106.
48.
Wang Z-Q., Liang J., Schellander K., Wagner EG, and Grigoriadis AE (1995). c-fos-induced osteosarcoma formation in transgenic mice: Cooperativity with c-jun and the role of endogenous c-fos. Cancer Res. 55: 6244-6251.
